Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

551.47
Delayed Data
As of 11:53am ET
 +11.44 / +2.12%
Today’s Change
299.73
Today|||52-Week Range
569.91
+34.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues665.7M725.8M802.3M869.6M
 
 
 
 
 
Cost of Goods Sold46.4M55.6M59.5M84.0M
 
 
 
 
 
Depreciation And Amortization13.0M14.0M14.1M16.0M
 
 
 
 
 
 
Operating ExpensesGross Income606.3M656.2M728.7M769.6M
 
 
 
 
 
General Expenses383.9M473.5M481.4M486.1M
 
 
 
 
 
Research And Development281.5M323.7M337.6M327.1M
 
 
 
 
 
Total Operating Expenses443.3M543.1M555.0M586.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income222.4M182.7M247.4M283.6M
 
 
 
 
 
Extraordinary Credit0.000.001.2M0.00
 
 
Extraordinary Charge-10.8M0.00-22.7M-942.0K
 
 
 
 
Interest Expense On Debt10.2M9.2M6.4M6.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income203.1M176.1M221.3M276.5M
 
 
 
 
 
Income Taxes-110.4M-96.4M-111.1M-200.5M
 
 
 
 
 
Net Income92.7M79.7M110.2M76.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS100.4M100.8M101.5M102.2M
 
 
 
 
 
Shares To Calculate EPS Diluted113.0M117.4M114.2M114.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.82$0.70$0.96$0.66
 
 
 
 
 
EPS Diluted$0.82$0.70$0.96$0.66
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account